BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25068472)

  • 1. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
    Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
    Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
    Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance.
    Taira AV; Merrick GS; Bennett A; Andreini H; Taubenslag W; Galbreath RW; Butler WM; Bittner N; Adamovich E
    Am J Clin Oncol; 2013 Apr; 36(2):116-20. PubMed ID: 22307210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.
    Bittner N; Merrick G; Taira A; Bennett A; Schattel A; Butler W; Galbreath R; Adamovich E
    Am J Clin Oncol; 2018 Aug; 41(8):723-729. PubMed ID: 27906722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
    Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
    BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
    Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
    Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.
    Bittner N; Merrick GS; Bennett A; Butler WM; Andreini HJ; Taubenslag W; Adamovich E
    Am J Clin Oncol; 2015 Jun; 38(3):300-3. PubMed ID: 23764680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation.
    Merrick GS; Galbreath RW; Bennett A; Butler WM; Amamovich E
    World J Urol; 2017 Jul; 35(7):1009-1013. PubMed ID: 27900453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?
    Pham KN; Porter CR; Odem-Davis K; Wolff EM; Jeldres C; Wei JT; Morgan TM
    J Urol; 2015 Sep; 194(3):674-9. PubMed ID: 25963186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.
    Bittner N; Merrick GS; Stewart R; Andreini H; Taubenslag W; Curtis R; Butler WM; Wallner KE
    Urol Oncol; 2011; 29(4):398-404. PubMed ID: 19945303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection.
    Merrick GS; Tennant A; Fiano R; Bennett A; Anderson R; Galbreath R; Butler WM; Adamovich E
    World J Urol; 2020 Feb; 38(2):361-369. PubMed ID: 31020423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
    Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
    Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
    BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
    Jin BS; Kang SH; Kim DY; Oh HG; Kim CI; Moon GH; Kwon TG; Park JS
    Korean J Urol; 2015 Sep; 56(9):624-9. PubMed ID: 26366274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer.
    Kawakami S; Kihara K; Fujii Y; Masuda H; Kobayashi T; Kageyama Y
    Int J Urol; 2004 Aug; 11(8):613-8. PubMed ID: 15285751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efficacy of Transrectal Ultrasound Guided Biopsy Versus Transperineal Template Biopsy of the Prostate in Diagnosing Prostate Cancer in Men with Previous Negative Transrectal Ultrasound Guided Biopsy.
    Nafie S; Wanis M; Khan M
    Urol J; 2017 Mar; 14(2):3008-3012. PubMed ID: 28299763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pelvic MRI combined with TRUS-guided transperineal template mapping biopsy for the diagnosis of prostate cancer].
    Li Q; Xie JJ; Cao WZ; Deng JP; Liu C; Cui Y; Shao Q; Shen H
    Zhonghua Nan Ke Xue; 2019 May; 25(5):408-413. PubMed ID: 32216225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy.
    Song W; Kang M; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Investig Clin Urol; 2019 Nov; 60(6):454-462. PubMed ID: 31692988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.